News for Emerald Health Therapeutics, Inc. (EMH.CN)

North America held largest medical marijuana market share in 2021. The pain management segment held the largest market share in 2021; the multiple...

The US Cannabis market will experience rapid growth due to the increasing research and development expenditure towards exploiting the medical benefits of...

According to Market.us, the Medical Marijuana Market size is anticipated to reach US$ 30.0 billion by 2032 expanding at a CAGR of 8.3% between 2023 and...

Medical Marijuana Market Trends and Insights By Product Type (Solid and Gas & Dissolvable/Powders), By Application (Alzheimer’s Disease, Cancer, and...

Emerald Health Therapeutics, Inc. announced today that its Plan of Arrangement with Skye Bioscience, Inc. has closed and that it has entered into agreements to divest its remaining cannabis... | November 11, 2022

Read Emerald Health Therapeutics, Inc. (OTCMKTS:EMHTF) Short Interest Update at ETF Daily News

San Diego, California, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company...

HYTN Cannabis Inc. wholly owned subsidiary of HYTN Innovations Inc., (CSE:HYTN) has developed and listed for sale its all-new Nano Gummies product.

VANCOUVER, British Columbia, Aug. 29, 2022 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (“

Share this article VANCOUVER – HYTN Innovations Inc. (CSE: HYTN) announced that its wholly owned subsidiary, HYTN Cannabis Inc., has been awarded a license b...

/PRNewswire/ -- The Insight Partners published latest research study on "Medical Marijuana Market Forecast to 2028 - COVID-19 Impact and Global Analysis By...

/PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced the second quarter...